Search all trials

Find therapies in clinical trials near you – page 12

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Dermatitis atopic

Not yet recruiting

Investigational

Study of IMG-007 injection to treat moderate to severe atopic dermatitis in adults

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Img-007

Contact Research Centre

Cough

Not yet recruiting

Investigational

A Randomized Dose‑Ranging Study of Nalbuphine Hydrochloride Extended‑Release Tablets in Adults with Refractory Chronic Cough

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Nalbuphine Hydrochloride

Contact Research Centre

Endometrial cancer

Not yet recruiting

Registered drugNo placebo

Study of GSK5733584 versus paclitaxel or doxorubicin in patients with advanced or recurrent endometrial cancer after platinum‑based chemotherapy and immunotherapy

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:GSK5733584

Contact Research Centre

Idiopathic pulmonary fibrosis

Not yet recruiting

Registered drugNo placebo

Randomized Phase 3 Study of Deupirfenidone (LYT‑100) versus Pirfenidone in Adults with Idiopathic Pulmonary Fibrosis

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Deupirfenidone

Contact Research Centre

Dermatitis atopic

Not yet recruiting

Investigational

Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Adults with Moderate to Severe Atopic Dermatitis (Phase 2 Study)

Investigational

Poland

Participants:18–64 years · 65+ years

Contact Research Centre

Ovarian cancer recurrent

Not yet recruiting

Registered drugNo placebo

Rinatabart Sesutecan with or without bevacizumab versus standard platinum‑based chemotherapy drug combination in patients with recurrent platinum‑sensitive ovarian cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Plasma cell myeloma

Not yet recruiting

Registered drugNo placebo

Ramantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Embolism venous

Not yet recruiting

Investigational

Safety, Tolerability and Effect of RBD4059 Injection in Adults with Prior VTE After Anticoagulant Therapy and Cancer Patients at High Risk of VTE

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Rbd4059

Contact Research Centre

Chronic graft versus host disease

Not yet recruiting

Registered drugNo placebo

Study of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy

Registered drugNo placebo

Poland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Malignant peritoneal neoplasm+2

Not yet recruiting

Registered drugNo placebo

Azenosertib versus drug combination in platinum‑resistant high‑grade serous ovarian, fallopian tube or primary peritoneal cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Azenosertib

Contact Research Centre

Hormone-refractory prostate cancer

Not yet recruiting

Registered drugNo placebo

Phase III Randomized Open‑Label Trial of BNT324 vs Docetaxel Plus Prednisone in Patients with Metastatic Castration‑Resistant Prostate Cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Docetaxel

Contact Research Centre

Heart failure with reduced ejection fraction

Not yet recruiting

Investigational

Evaluating the efficacy and safety of CRD-4730 in patients with heart failure with reduced ejection fraction

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Crd-4730

Contact Research Centre

Find therapies in clinical trials near you – page 12

347 trials match your criteria

Dermatitis atopic

Study of IMG-007 injection to treat moderate to severe atopic dermatitis in adults

Cough

A Randomized Dose‑Ranging Study of Nalbuphine Hydrochloride Extended‑Release Tablets in Adults with Refractory Chronic Cough

Endometrial cancer

Study of GSK5733584 versus paclitaxel or doxorubicin in patients with advanced or recurrent endometrial cancer after platinum‑based chemotherapy and immunotherapy

Idiopathic pulmonary fibrosis

Randomized Phase 3 Study of Deupirfenidone (LYT‑100) versus Pirfenidone in Adults with Idiopathic Pulmonary Fibrosis

Dermatitis atopic

Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Adults with Moderate to Severe Atopic Dermatitis (Phase 2 Study)

Ovarian cancer recurrent

Rinatabart Sesutecan with or without bevacizumab versus standard platinum‑based chemotherapy drug combination in patients with recurrent platinum‑sensitive ovarian cancer

Plasma cell myeloma

Ramantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant

Embolism venous

Safety, Tolerability and Effect of RBD4059 Injection in Adults with Prior VTE After Anticoagulant Therapy and Cancer Patients at High Risk of VTE

Chronic graft versus host disease

Study of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy

Malignant peritoneal neoplasm+2

Azenosertib versus drug combination in platinum‑resistant high‑grade serous ovarian, fallopian tube or primary peritoneal cancer

Hormone-refractory prostate cancer

Phase III Randomized Open‑Label Trial of BNT324 vs Docetaxel Plus Prednisone in Patients with Metastatic Castration‑Resistant Prostate Cancer

Heart failure with reduced ejection fraction

Evaluating the efficacy and safety of CRD-4730 in patients with heart failure with reduced ejection fraction

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.